# Milestone

> Milestone is a VC fund in Shanghai backing Health Care, Biotechnology and Medical. See 12 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Shanghai, China
- Total investments: 12
- Last investment: Mar 2026
- Lead investor: 17%
- Last updated: Aug 2026
- Website: http://www.smilestone.com.cn/

Milestone is an asset management organization.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 25% |
| Biotechnology | 3 | 25% |
| Medical | 2 | 17% |
| Video | 1 | 8% |
| Mobile | 1 | 8% |

22 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 4 | 33% |
| Series C | 2 | 17% |
| Venture - Series Unknown | 2 | 17% |
| Seed | 1 | 8% |
| Angel | 1 | 8% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 7 | 58% |
| South Korea | 2 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| ROKIT Healthcare | ROKIT Healthcare provides hardware, software, and application support. Their custom fabrication technologies deliver solutions to the design, creation, and applications of three-dimensional systems. They provide suffering patients and humans with a hyper-personalized medical organ regeneration solution. They apply artificial intelligence and 3dbioprinting technology to regenerate the skin and cartilage organs through surgery for patients. | $42.5M | Post-IPO Equity | Mar 10, 2026 | http://www.rokithealthcare.com |
| AriBio | AriBio is a biotechnology firm dedicated to developing therapeutic solutions for neurodegenerative disorders. At AriBio, polypharmacology is strengthened by the capabilities of advanced AI technologies. Utilizing the ARIDD™ platform, the company explores extensive molecular databases, forecasting interactions that encompass various targets andmechanisms. By harnessing AI, AriBio strives to enhance drug efficacy and broaden potential therapeutic applications. ARIDD™ serves as a drug development platform that enhances the discovery and creation of polypharmacological medications. | $83.6M | Venture - Series Unknown | Feb 18, 2022 | http://www.aribio.com/ |
| Yuyuan Technology | Ugion is an augmented and virtual reality R&D company that provides marketing display, amusement interaction, and education services. |  | Series A | Jan 11, 2022 | http://www.ugion.com/ |
| ImmuneOnco Biopharma | ImmuneOnco Biopharma, founded in June of 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an early stage biopharmaceutical company dedicated to the development and commercialization of novel cancer immunotherapy products designed to reverse cancer cell-induced immune inhibition and to actively eradicate cancer cells. | $100M | Series C | Jan 01, 2022 | http://immuneonco.com/ |
| ImmuneOnco Biopharma | ImmuneOnco Biopharma, founded in June of 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an early stage biopharmaceutical company dedicated to the development and commercialization of novel cancer immunotherapy products designed to reverse cancer cell-induced immune inhibition and to actively eradicate cancer cells. | $100M | Venture - Series Unknown | Dec 31, 2021 | http://immuneonco.com/ |
| ImmuneOnco Biopharma | ImmuneOnco Biopharma, founded in June of 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an early stage biopharmaceutical company dedicated to the development and commercialization of novel cancer immunotherapy products designed to reverse cancer cell-induced immune inhibition and to actively eradicate cancer cells. | $25M | Series B | Oct 10, 2020 | http://immuneonco.com/ |
| Cosemitech | Cosemitech is a cutting-edge semiconductor solution provider. The R&D team has more than 12 years of experience in automotive electronics IC development. The chips developed by the team are widely used in Europe, Europe, Germany, France, Italy and the United States. On the car. Committed to providing customers with power devices, industrialcontrol, automotive electronics solutions. From sensor technology, energy management and energy-saving technologies, industrial control to automotive electronics, from work to entertainment, Yirui Semiconductor will strive to contribute and play an active and innovative role in enriching people's lives. | $1.4M | Seed | Jun 04, 2019 | http://www.cosemitech.com/ |
| Seek-Data | Seek-Data is a smart quantitative investment research company. | $730K | Angel | Jan 08, 2019 |  |
| ImmuneOnco Biopharma | ImmuneOnco Biopharma, founded in June of 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an early stage biopharmaceutical company dedicated to the development and commercialization of novel cancer immunotherapy products designed to reverse cancer cell-induced immune inhibition and to actively eradicate cancer cells. |  | Series A | Apr 11, 2018 | http://immuneonco.com/ |
| Ulucu | Shanghai Ulucu Electronic Technology Co.,Ltd. (悠络客电子科技) is a cloud-based video monitoring and network monitoring operator that provides chain enterprises, logistics enterprises, education institutions and governments with network monitoring operation services. Its services include the research and development, selling, installation, platformoperation, after-sales services, securities services of software and hardware and other whole solutions. Ulucu has a strong independent research and development team with achievements in embedded technology of hardware to streaming media transmission technology, P2P transmission technology, cloud server technology, and more.. Its products and technology has received many national invention patents. Ulucu aims to establish a strong and complete national service system. Currently, Ulucu has over 300 national service network stations including after-sales service stations and joint service providers which cover all provinces and cities. | $12M | Series C | Jan 08, 2018 | http://www.ulucu.com/ |

10 of 12 investments shown.

## Co-investors
- [Lilly Asia Ventures](https://shizune.co/investors/profile/lilly-asia-ventures) — VC Fund, 3 deals together
- [CASH Capital](https://shizune.co/investors/profile/cash-capital) — VC Fund, 2 deals together
- [CCB Trust](https://shizune.co/investors/profile/ccb-trust-co) — VC Fund, 2 deals together
- [CDF-Capital](https://shizune.co/investors/profile/cdf-capital) — VC Fund, 2 deals together
- [Founder H Fund](https://shizune.co/investors/profile/founder-h-fund) — VC Fund, 2 deals together
- [Sunshine Insurance Group](https://shizune.co/investors/profile/sunshine-insurance-group-co-ltd) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [HOWZAT Partners](https://shizune.co/investors/profile/howzat-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Travel Investors in China](https://shizune.co/investors/travel-investors-china)
- [Travel VC Funds in China](https://shizune.co/investors/travel-vc-funds-china)

## FAQ

### What does Milestone invest in?

Milestone invests primarily in Health Care, Biotechnology and Medical startups, most often at Series A and Series C stage. Most of the 12 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Milestone last invest?

The most recent investment recorded for Milestone closed in Mar 2026. Shizune tracks 12 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co